Related Experiment Video
Updated: Sep 29, 2025
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.0K
CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity
Ferenc Fekete1,2, Katalin Mangó1, Annamária Minus1
1Institute of Enzymology, Research Centre for Natural Sciences, Magyar Tudósok 2, H-1117 Budapest, Hungary.
Pharmaceutics
|March 26, 2022
Summary
Genetic variations in CYP1A2 (cytochrome P450 family 1 subfamily A member 2) do not reliably predict enzyme activity. Leukocyte mRNA expression is a better indicator of a patient's CYP1A2-metabolizing capacity.
Area of Science:
- Pharmacogenomics
- Drug Metabolism
- Enzyme Kinetics
Background:
- Cytochrome P450 1A2 (CYP1A2) is a key enzyme in metabolizing drugs and carcinogens.
- Existing data on CYP1A2 genetic polymorphisms and their impact on enzyme activity are inconsistent.
- The clinical significance of specific CYP1A2 variants remains unclear.
Purpose of the Study:
- To investigate the impact of specific CYP1A2 genetic variants on mRNA expression and enzyme activity.
- To evaluate the predictive value of CYP1A2 genotyping for enzyme function in Caucasian populations.
- To explore the role of non-genetic factors in CYP1A2 phenotype estimation.
Main Methods:
- Analysis of CYP1A2 genetic variants (−3860G>A, −2467delT, −739T>G, −163C>A, 2159G>A) in human liver tissues and psychiatric patients.
- Measurement of CYP1A2 mRNA expression and phenacetin O-dealkylation activity.
- Assessment of haplotypes and non-genetic factors like co-medication and lifestyle.
Main Results:
- The −163C>A polymorphism, often associated with CYP1A2*1F, was found in multiple haplotypes and was rarer than previously reported.
- The −163C>A polymorphism did not significantly increase CYP1A2 mRNA expression or activity.
- Hepatic CYP1A2 activity correlated with mRNA expression in liver or leukocytes, not with genetic polymorphisms.
- Non-genetic factors minimally improved genotype-phenotype correlation.
Conclusions:
- CYP1A2 genotyping is not a reliable method for predicting CYP1A2 enzyme function.
- CYP1A2 mRNA expression in leukocytes serves as a valuable indicator of a patient's CYP1A2-metabolizing capacity.
- Understanding non-genetic factors is crucial but insufficient for accurate phenotype prediction based on genotype alone.
Related Concept Videos
01:58Cell Specific Gene Expression
14.1K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.1K
01:16Hepatic Drug Excretion: Influencing Factors
252
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
252
02:23Master Transcription Regulators
7.2K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
95
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
95
01:14Hepatic Drug Clearance: Role of Transporters
126
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
126